MARATTO

article · International Journal for Quality in Health Care

Navigating Regulatory Pathways for Access to Innovative Medicines in Tunisia

Abstract

This study highlights the evolving regulatory landscape for IM in Tunisia. The growing number of applications signals a shift toward improved access, but further regulatory reforms are needed to accelerate patient access to innovation.

Research topics

  • Pharmaceutical Economics and Policy
  • Health Systems, Economic Evaluations, Quality of Life
  • Biomedical Ethics and Regulation

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/intqhc/mzag046

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.